SUDA Ltd (ASX: SUD) is a drug delivery company utilising its proprietary OroMist&reg;oromucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of ...

SUDA Ltd.

AI Magazine

Business Chief Asia

Business Chief Middle East

Business Chief North America

Business Chief UK & Europe

Construction Digital

Cyber Magazine

Data Centre Magazine

EV Magazine

Energy Magazine

FinTech Magazine

Food Digital

Healthcare Digital

InsurTech Magazine

Manufacturing Digital

March8

Mining Digital

Mobile Magazine

Procurement Magazine

Supply Chain Magazine

Sustainability Magazine

Technology Magazine

Magazine

Companies

Interviews

Videos

Events

Lists

Content

About

Editorial

Advertise

Press Releases

More

Articles

Top 10

News & Articles

Magazines

Company Reports

Reports & Whitepapers

Hospitals

Technology

Medical Services & Devices

Procurement & Supply Chain

Digital Healthcare

Telehealth & COVID-19

Sectors

Sustainability LIVE London 2024

Other Events

PA Consulting: People Want 'Stackable' Healthcare Products

HIV Testing Landmark Highlights Ongoing AIDS Problems

Top 10: Biggest Pharma companies in Europe

Transforming Healthcare: CFO & CEO Strategy & Vision

Schneider's Blum on Electricity 4.0 and Healthcare

Research Breakthrough Promises New Lupus Treatments

Healthcare Systems Worldwide Hit by Global IT Outage

SUDA Ltd.

Executives in SUDA Ltd.

Nick Woolf

Chief Business Officer